PIK3CA hotspot mutations p. H1047R and p. H1047L sensitize breast cancer cells to thymoquinone treatment by regulating the PI3K/Akt1 pathway
Ju Zhou, Saber İmani, Marzieh Dehghan Shasaltaneh, Shuguang Liu, Tao Lü, Junjiang Fu
Topics & Concepts
ThymoquinoneAKT1Cancer researchBreast cancerPI3K/AKT/mTOR pathwayBiologyGeneticsMedicineOncologyInternal medicineComputational biologyBioinformaticsCancerSignal transductionBiochemistryAntioxidantNigella sativa pharmacological applicationsChemotherapy-induced organ toxicity mitigationHedgehog Signaling Pathway Studies